Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Lymphoid

Explore clinical trials studying Leukemia, Lymphoid. Study availability and eligibility vary by location and protocol.

3,018 public trials 549 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Lymphoid trial results

Completed

CLBR001 and SWI019 in Patients With Relapsed / Refractory B-cell Malignancies

NCT04450069

Conditions
Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +47 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California at San Diego San Diego, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States
View Trial Details
Completed

A Study of Revumenib in Combination With Chemotherapy in Participants With R/R Acute Leukemia

NCT05326516

Conditions
Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, +17 more
Locations
  • University of California, San Francisco (UCSF) Benioff Children's Hospital San Francisco, California, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Children's Mercy Hospital Kansas City, Missouri, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details
Completed

Efficacy and Safety of Tenalisib (RP6530) in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

NCT04204057

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
Locations
  • University Multiprofile Hospital for Active Treatment "Dr Georgi Stranski" Ltd., Pleven, Bulgaria
  • University Multiprofile Hospital for Active Treatment "Sv Ivan Rilski" Ltd Sofia, Bulgaria
  • Ltd. M.Zodelava Hematology Centre Tbilisi, Georgia
  • Medivest - Institute of Hematology and Transfusiology Tbilisi, Georgia
View Trial Details
Completed

A Study in Previously Untreated Chronic Lymphocytic Leukemia (CLL) Subjects, Excluding Those With the 17p Deletion, to Evaluate Debulking Regimens Prior to Initiating Venetoclax Combination Therapy

NCT03406156

Conditions
Chromosome 17 deletion, Chronic Disease, Chronic Lymphocytic Leukemia (CLL), +17 more
Locations
  • Arizona Oncology Associates, PC-HOPE /ID# 202335 Tempe, Arizona, United States
  • Rocky Mountain Cancer Centers - Denver Midtown /ID# 202328 Denver, Colorado, United States
  • MidAmerica Division, Inc. /ID# 201099 Kansas City, Missouri, United States
  • Oncology Hematology Care, Inc. /ID# 202397 Cincinnati, Ohio, United States
View all 15 locations
View Trial Details
Completed

A Safety and Preliminary Efficacy Study of CC-99282 in Combination With Obinutuzumab in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT04434196

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +16 more
Locations
  • Local Institution - 106 Boston, Massachusetts, United States
  • Local Institution - 104 Columbus, Ohio, United States
  • Local Institution - 101 Portland, Oregon, United States
  • Local Institution - 107 Dallas, Texas, United States
View all 15 locations
View Trial Details
Completed

Dose-escalation Study of Oral Administration of S 55746 in Patients With Chronic Lymphocytic Leukaemia and B-Cell Non-Hodgkin Lymphoma

NCT02920697

Conditions
B-Cell Non-Hodgkin Lymphoma (NHL), Blood Protein Disorders, Cardiovascular Diseases, +22 more
Locations
  • The Alfred Hospital Malignant Haematology & Stem Cell Transplantation Services Melbourne, Australia
  • Hopital Claude Huriez Lille, France
  • CHU de Nantes Nantes, France
  • Centre hospitalier Lyon Sud Pierre-Bénite, France
View all 18 locations
View Trial Details

Related conditions